EU-501

N/A

Report date: 2022/10/26 15:47:44

Base Information

Drug NameEU-501

Drug Alias NameEU-501EU501

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-Tumor necrosis factor receptor superfamily member 9Anti-HER2

TargetsTumor necrosis factor receptor superfamily member 9Receptor protein-tyrosine kinase erbB-2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesEutilex

China Registration ClassN/A

Develop Information

Active CompaniesEutilex

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A